Literature DB >> 23978482

Associations between single nucleotide polymorphisms in thyroid hormone transporter genes (MCT8, MCT10 and OATP1C1) and circulating thyroid hormones.

Greet L Roef1, Ernst R Rietzschel, Tim De Meyer, Sofie Bekaert, Marc L De Buyzere, Caroline Van daele, Kaatje Toye, Jean-Marc Kaufman, Youri E Taes.   

Abstract

BACKGROUND: Thyroid hormone (TH) action takes place intracellularly; therefore, transport across the plasma membrane by specific TH transporters, such as MCT8, MCT10 and OATP1C1, is necessary. Several single nucleotide polymorphisms (SNPs) in these genes were reported to be associated with TH concentrations; however, results have been inconsistent.
METHODS: Six SNPs in TH transporter genes (rs5937843-G/T and rs6647476-T/C in MCT8, rs14399-C/A in MCT10, rs10444412-C/T, rs10770704-C/T and rs36010656-C/A in OATP1C1) were genotyped in 2 cohorts; one consisting of 2416 men and women aged 35-55 yrs (Asklepios), and the other of 941 men aged 25-45 yrs (Siblos), using KASPar technology. TSH, FT3, FT4 and total T3 were determined by immuno-electrochemiluminescence in both cohorts; in the second cohort additional determination of total T4 by electrochemiluminescence and of reverse T3 (rT3) and thyroid binding globulin (TBG) by radioimmunoassays was performed.
RESULTS: The first SNP in MCT8 (rs5937843-G/T) was inversely associated with FT4 concentrations in men but not in women. In Siblos, this SNP showed also negative associations with TT4 and rT3; in men from Asklepios a trend for positive association with TSH was observed. The second SNP in MCT8 (rs6647476-T/C) was negatively associated with FT3 levels in men from the Siblos and the Asklepios cohort. In addition, an inverse association with TT3 levels in men from the Siblos was observed. Rs36010656 (C/A) in OATP1C1 was not in Hardy-Weinberg equilibrium and therefore excluded from further analyses. The other 2 SNPs in OATP1C1 (rs10444412-C/T and rs10770704-C/T) and the SNP in MCT10 (rs14399-C/A) were not related to TH levels in either cohort.
CONCLUSION: Two SNPs in MCT8 were related to circulating thyroid hormone levels in men but not in women: the rs5937843 polymorphism (G/T) was inversely associated with FT4 levels and the rs6647476 (T/C) polymorphism related negatively to circulating FT3.
© 2013.

Entities:  

Keywords:  Monocarboxylate transporter 8 and 10; Organic anion transporting polypeptide 1C1; Single nucleotide polymorphism (SNP); TSH; Thyroid hormone concentrations; Thyroid hormone transporters

Mesh:

Substances:

Year:  2013        PMID: 23978482     DOI: 10.1016/j.cca.2013.08.017

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

2.  Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association.

Authors:  B Biondi; L Bartalena; L Chiovato; A Lenzi; S Mariotti; F Pacini; A Pontecorvi; P Vitti; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2016-07-29       Impact factor: 4.256

3.  Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 + L-T4 Combination Treatment - Data Using a Blind, Randomized, Clinical Study.

Authors:  Allan Carlé; Jens Faber; Rudi Steffensen; Peter Laurberg; Birte Nygaard
Journal:  Eur Thyroid J       Date:  2017-04-24

4.  Targeting the right population for T3 + T4 combined therapy: where are we now and where to next?

Authors:  Tommaso Porcelli; Domenico Salvatore
Journal:  Endocrine       Date:  2020-06-22       Impact factor: 3.633

5.  Genome-wide association meta-analysis for total thyroid hormone levels in Croatian population.

Authors:  Ivana Gunjača; Antonela Matana; Thibaud Boutin; Vesela Torlak; Ante Punda; Ozren Polašek; Vesna Boraska Perica; Caroline Hayward; Tatijana Zemunik; Maja Barbalić
Journal:  J Hum Genet       Date:  2019-03-01       Impact factor: 3.172

Review 6.  New insights into thyroid hormone action.

Authors:  Arturo Mendoza; Anthony N Hollenberg
Journal:  Pharmacol Ther       Date:  2017-02-04       Impact factor: 12.310

7.  Participation of Monocarboxylate Transporter 8, But Not P-Glycoprotein, in Carrier-Mediated Cerebral Elimination of Phenytoin across the Blood-Brain Barrier.

Authors:  Ryuta Jomura; Shin-Ichi Akanuma; Björn Bauer; Yukiko Yoshida; Yoshiyuki Kubo; Ken-Ichi Hosoya
Journal:  Pharm Res       Date:  2021-02-01       Impact factor: 4.200

Review 8.  Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults.

Authors:  Philippe Caron; Solange Grunenwald; Luca Persani; Françoise Borson-Chazot; Remy Leroy; Leonidas Duntas
Journal:  Rev Endocr Metab Disord       Date:  2021-10-20       Impact factor: 9.306

9.  Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design.

Authors:  Ritu Madan; Francesco S Celi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-08       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.